About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, May 11th, 2012

The QualityStocks
Daily Stock List

graphic
graphic

Cardium Therapeutics, Inc. (CXM)

FeedBlitz, Greenbackers, SmarTrend Newsletters, CRWEPicks, PennyOmega, and DrStockPick reported earlier on Cardium Therapeutics, Inc. (CXM), and we highlight the Company as "One to Watch" next week here at the QualityStocks Daily Newsletter.

Cardium Therapeutics, Inc. focuses on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering, and other economic monetizations. The Company's current medical opportunities portfolio focuses on health sciences and regenerative medicine. It includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium® Health Sciences healthy lifestyle product platform. Listed on the NYSE Amex, Cardium Therapeutics has their headquarters in San Diego, California.

Cardium's lead commercial product is the Excellagen™ topical gel for wound care management. It has recently received FDA clearance for marketing and sale in the U.S.  Excellagen™ is a highly refined fibrillar flowable bovine collagen topical gel (2.6 percent) intended to support a favorable wound healing environment. Excellagen's unique high molecular weight bovine Type I collagen formulation is topically applied through easy-to-control, pre-filled single use syringes.  

The Company's lead clinical development product candidate Generx® is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. Cardium's MedPodium™ is a portfolio of premium, science-based, easy-to-use nutraceuticals, metabolics, and aesthetics designed to promote health and well-being. Cardium also continues to evaluate new technologies and business opportunities.

In July 2009, Cardium completed the sale of their InnerCool Therapies medical device business to Royal Philips Electronics. This represents the first asset monetization from the Company's biomedical investment portfolio. Cardium earlier received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell their Excellagen™ professional-use, sterile, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers, and other dermal wounds.

In January of this year, Cardium Therapeutics announced that they entered into their first international agreement for the commercialization of Excellagen™ in the South Korean market. Cardium entered into a marketing and distribution agreement with BL&H Co. Ltd. BL&H is an established pharmaceutical company based in Korea. The agreement is for the commercialization of Excellagen Formulated Fibrillar Collagen Gel in the South Korean market under a transfer price arrangement. Additionally, in January the Company initiated the ASPIRE clinical study at leading medical centers in Russia for Cardium's Generx® cardiovascular product candidate. In March, Cardium initiated the U.S. market introduction of the Excellagen™ product for diabetic foot ulcers and other dermal wounds.

Last month, Cardium Therapeutics exhibited their new FDA-cleared Excellagen® professional-use, syringe-based wound care product for the management of diabetic foot ulcers, pressure ulcers, and other dermal wounds at the 2012 Spring Symposium on Advanced Wound Care (SAWC), which took place April 19 - 22, 2012 in Atlanta, Georgia.

We're tracking Cardium Therapeutics, Inc. (CXM) on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Cardium Therapeutics, Inc. (CXM) closed Friday's trading session at $0.24, up 4.35%, on 721,439 volume with 542 trades. The average volume for the last 60 days is 424,912. The 52-week low/high is $0.13/$0.59.

Innovative Food Holdings, Inc. (IVFH)

Based in Naples, Florida, Innovative Food Holdings, Inc., through their subsidiaries, provides origin-specific perishables and specialty products to end users. The Company supplies chefs with unique, organic, sustainable and artisanal products sourced from all regions of the world. Innovative Food Holdings serves restaurants, hotels, country clubs, national chain accounts, casinos, and catering houses. The Company's shares trade on the OTC Bulletin Board.

Innovative Food Holdings distributes approximately 5,000 perishable and specialty food products. This includes origin-specific seafood, domestic and imported meats, exotic game and poultry, artisanal cheeses, and caviar. Products also include wild and cultivated mushrooms, micro-greens, heirloom and baby produce, organic farmed and manufactured food products, estate-bottled olive oils, and aged vinegars.

Perishable product undergoes delivery direct to the Company's kitchen the next day via FedEx overnight delivery. Non-perishable product delivers direct to their customers' via FedEx Saver.

The Company has their For The Gourmet, Inc. offering. For The Gourmet is a wholly owned subsidiary of Innovative Food Holdings. Via their website, and through additional sales channels, For The Gourmet provides the highest quality gourmet food products to the retail consumer market under the For The Gourmet line.  An in-house team of culinary-trained chefs has chosen all the products offered by For The Gourmet. The products represent the "best in class" of products from small artisanal growers and producers.

Furthermore, they include a full line of products used by professional chefs in their premier recipes. The Company offers the freshest product delivered direct without additional days of transportation and storage by local distributors. Their logistics specialists always know the location of customers' orders. In addition, they source specific hard-to-find products for their customers. Products are handpicked and hand-sealed to ensure freshness. The farms and boats are the only hands to touch these products before they reach customers.

In late March 2012, Innovative Food Holdings announced full year 2011 record results. Net revenues were a record $11.5 million for the year ended December 31, 2011, an approximate 17 percent increase compared to net revenues of $9.8 million for 2010. The Company's EBITDA (without operations related stock, warrant and options related gains/losses) increased by over 25 percent to $510,645, compared to $405,318 in EBITDA (without operations related stock, warrant and options related gains/losses) for 2010.

Highlights for 2011 for the Company include 29 consecutive months of month over month record revenues. Innovative Food Holdings has a high quality demographic. They have a foodservice customer base of more than 24,000 professional chefs in some of the finest restaurants, hotels and other Foodservice establishments across the U.S.

Innovative Food Holdings, Inc. (IVFH) closed at $0.007, even with yesterday’s close, on 1,000 volume. The average volume for the last 60 days is 769,905. The 52-week low/high is $0.002/$0.01.

Liberator Medical Holdings, Inc. (LBMH)

Wall Street Resources reported this week on Liberator Medical Holdings, Inc. (LBMH), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, Liberator Medical Holdings, Inc. and their subsidiaries distribute direct-to-consumer durable medical supplies for seniors in the U.S.  Liberator Medical Supply, Inc. is a wholly owned subsidiary of Liberator Medical Holdings. The Company offers more than 5,000 products to Medicare-eligible patient populations with chronic conditions requiring repeat-orders of maintenance supplies. Founded in 1906, Liberator Medical Holdings is based in Stuart, Florida.

Liberator Medical Supply established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. Liberator has recognition for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance.

Liberator's revenue mainly comes from supplying products to meet the rapidly growing demand from urological, ostomy, mastectomy and diabetes patients. For example, Liberator Medical ostomy supplies include colostomy, ileostomy and urostomy supplies. The Company offers ostomy supplies from all of the major ostomy supply manufacturers including Coloplast, Genairex, Hollister and Convatec.

The Company communicates with patients and their physicians regularly regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.

The Company markets their products directly to consumers primarily through targeted media and direct response television advertising. Liberator's customer service representatives are specifically trained to communicate with Medicare-eligible beneficiaries. The Company's operating platforms enable them to collect and process required documents from physicians and customers, and bill and collect amounts due from Medicare and/or other government agencies and/or third party payers and/or customers.

The Compliance Team has awarded Exemplary Provider Accreditation to Liberator Medical Holdings. They are a national accreditation organization authorized by the federal government's Centers for Medicare and Medicaid Services. This accreditation certifies that Liberator maintains the strictest standards of operation throughout their company.

Liberator Medical Holdings, Inc. (LBMH) closed Friday's trading session at $1.01, up 6.32%, on 130,594 volume with 16 trades. The average volume for the last 60 days is 18,926. The 52-week low/high is $0.75/$1.49.

Cantex Mine Development Corp. (CD.V)

We are highlighting Cantex Mine Development Corp. (CD.V) here at the QualityStocks Daily Newsletter.

Cantex Mine Development Corp.'s principal business activity is the acquisition and exploration of mineral properties for commercial mineral deposits. The Company's primary project is in northwestern Yemen where they own exclusive exploration licenses over a 1,583 square kilometer area. Cantex lists on the TSX Venture Exchange. The Company has their headquarters in Kelowna, British Columbia.

In Yemen, Nickel, Copper, Cobalt and Platinum have been discovered on three of the Company's licenses at Suwar, Wadi Qutabah and Al Masna. A gold deposit has been discovered on their Al Hariqah project. Cantex's second project is in Nevada. Here, the Company has a 100 percent interest in 7 gold exploration prospects secured with 267 claims. Cantex is currently seeking joint venture partners to advance the projects. 

In addition, they have two 1,000-plus hectare claim blocks around a new belt of gold mineralization discovered approximately 100 kilometers northeast of Mayo, Yukon Territory, Canada. Cantex has a 100 percent interest in the two claim blocks strategically located near ATAC Resources' discoveries. A 50-claim block has been staked adjacent to the eastern end of ATAC's claim block. Cantex's claims are on strike with the recent Osiris discovery where drilling intersected 65.2 meters of 4.65 g/t gold. An additional 48-claim block has been staked over the source areas of several arsenic anomalies as reported in government stream sediment geochemical maps.

Recently, Cantex Mine Development reported that all analytical results are complete with respect to follow-up sampling of the Company's two gold claim groups in central Yukon as well as their approximately 2,500 heavy mineral samples collected from un-staked land extending over 30,000 square kilometers. These samples were collected from areas underlain by favorable geology for Carlin-style gold deposits.

Gold and key pathfinder elements for Carlin-style mineralization have been detected on both claim groups staked by Cantex in 2011.  Additional sampling aimed at establishing drill targets on both sets of claims is being planned for this summer.

Eighty-seven gold anomalies accompanied by key pathfinder elements (arsenic, antimony, thallium, etc.) suggest that local rather than placer sources of gold have been detected.  Forty-eight samples are anomalous in all key pathfinder elements. This is indicative of detecting new local sources of Carlin-style gold mineralization within the 30,000 square kilometers explored.

Cantex Mine Development Corp. (CD.V) closed Friday's trading session at $0.03, even with yesterday’s close, on 193,000 volume. The 52-week low/high is $0.03/$0.09.

ChromaDex Corp. (CDXC)

RedChip, FeedBlitz, SmallCap Network, and SmallCapVoice reported recently on ChromaDex Corp.(CDXC), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ChromaDex Corp. is a natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. The Company has an expanding pipeline of new ingredients. This includes their pTeroPure® pterostilbene for which they have worldwide, exclusive patent pending rights. ChromaDex's shares trade on the OTC Bulletin Board. The Company has their headquarters in Irvine, California.

ChromaDex is also investigating pTeroPure for the skincare and pharmaceutical markets, among others. pTeroPure is currently undergoing study in a human clinical trial at the University of Mississippi. The Company's pTeroPure® was named the 2010 North American Most Promising Ingredient of the Year by the independent research company Frost & Sullivan. It is the key novel ingredient in BluScience™, ChromaDex's new line of dietary supplements. BluScience™ dietary supplements are available at a major drug store chain, a national products retailer, and an online retailer.

Pterostilbene has superior biological activity, better oral bioavailability and metabolizes more slowly in the body than other antioxidant polyphenols (phytochemicals that tend to prevent or neutralize the damaging effects of free radicals), allowing more time for their antioxidant activities to act. Along with several other effects, pterostilbene has shown great promise for supporting cardiovascular health, cognitive function and anti-aging.

In April, ChromaDex announced that the U.S. Patent and Trademark Office (USPTO) granted patent #8,133,917 pertaining to the ingredient pterostilbene, licensed exclusively to ChromaDex. This is the first ChromaDex-licensed patent issued for pterostilbene. Several more patents are pending.

Yesterday, ChromaDex announced their financial results for the first quarter of 2012. The Company recorded revenue of $1,785,006 during the first quarter of 2012 compared to $2,539,245 for the same period in 2011. The net loss attributable to common stockholders for the quarter ended March 31, 2012, was $4,431,853 compared to a net loss of $1,156,385 for the same period in 2011.

The net loss in the first quarter of 2012 was primarily impacted by promotions and discounts related to the launch of ChromaDex's BluScience™ products. As of March 31, 2012, cash, cash equivalents, and marketable securities totaled more than $5.8 million.

ChromaDex Corp. (CDXC) closed Friday's session at $0.55, down 5.17%, on 193,070 volume with 53 trades. The average volume for the last 60 days is 216,752. The 52-week low/high is $0.48/$1.84.

Command Security Corp. (MOC)

TaglichBrothers, SmarTrend Newsletters, and Wall Street Resources reported earlier on Command Security Corp. (MOC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Command Security Corp. is a provider of affordable contract security services. The Company has offices nationwide and operations at numerous major international airports. Command Security provides complete, customized and cost-effective security solutions for industries, businesses, institutions and organizations of all sizes. The Company offers Security Services and Aviation Services. Command Security has their corporate headquarters in Lagrangeville, New York.

Command Security began their operations as R. J. Thompson, Inc. in 1980. In 1983, the Company discontinued the use of the R.J. Thompson name and began operating as Command Security. In 1995, Command Security acquired the assets of United Security Group - a New York regional security services company with operations also in California. In April 2007, Command Security completed the acquisition of California-based Brown Security Services, P.A., including their wholly owned subsidiaries, Strategic Security Services, Inc. and Rodgers Police Patrol, Inc.

The Company principally provides uniformed security officers and aviation services through more than 40 offices. They operate in 30 states throughout the United States. In conjunction with providing these services, Command Security assumes responsibility for recruiting, hiring, training and supervising all operating personnel as well as compensating such personnel and providing them with uniforms, fringe benefits and workers' compensation insurance.

For Security Services, the Company and their subsidiaries provide their services to governments, quasi-governmental, health, educational and financial institutions, residential and commercial property management companies, and industrial, distribution, logistics and retail customers. Security services include providing armed and unarmed uniformed security personnel for access control, mobile patrols, traffic control, security console/system operators, fire safety directors, and communication, reception, concierge and front desk/doorman operations.

For Aviation Services, the Aviation Safeguards division of the Company provides an array of aviation security and customer service functions. These include security for airlines, aircraft, passengers and cargo. These also include baggage screening, wheelchair escort services featuring their proprietary SmartWheel™ and SmartTracker™ technology, special escort services, and skycap services.

Command Security Corp. (MOC) closed Friday's trading session at $1.19, even with yesterday’s close. The average volume for the last 60 days is 21,332. The 52-week low/high is $1.09/$1.95.

Organa Gardens International, Inc. (OGNG)

Momentum Hunter, OTCPicks, and HotStockCafe reported earlier on Organa Gardens International, Inc. (OGNG), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, Organa Gardens International Inc. has a vertical hydroponics farming system built to make the most efficient use of light, energy, water, land, and temperature and production cycle. This is while growing the highest quality and healthiest plants in an optimum, consistent environment unaffected by weather. The Organa Garden Systems (OGS) provide a means for food production and consumption change to global environmental and ecological sustainability through vertical hydroponics rotary farming. Organa Gardens International has their corporate headquarters in Patchogue, New York.

There exist two OGS models. These are the Discovery (OGS-D) and the Enterprise (OGS-E). The OGS-D and OGS-E are rotary hydroponics vertical farming systems designed with serviceability, ease-of-use and maximum harvest in mind. Both models are modular. This allows them to undergo expansion by stacking them. The specially designed waterwheel technology allows the fully automated system to recycle and reuse 95 percent of the water used while requiring a negligible amount of energy to run.

The Discovery (OGS-D) is a strong, low cost ABS plastic model for the home gardener. The OGS-D provides for high density, high yield production. Engineered and designed for use in small farms or urban warehouses, the OGS-D provides a sustainable, continual source of agricultural products.

The Organa Garden System-Enterprise (OGS-E) is a powder-coated steel, professional grade vertical farming hydroponics system designed for use in large-scale commercial farming and growing operations. The Organa Garden Systems provide for fresh, nutritious and abundant produce, year-round. Localized year-round farming is possible, eliminating costly transportation, spoilage and pollution. The Systems reduce the use of pesticides and preservatives. They foster urban renewal and sustainable community building, energy and water conservation and harvests that are more frequent.   

Both models are full turnkey systems. They consist of a sump pump, stackable stand, collection tray, and a waterwheel with planting slots as well as a grow light.

Organa Gardens International, Inc. (OGNG) closed at $0.0047, up 62.07%, on 2,120,667 volume with 40 trades. The average volume for the last 60 days is 372,666. The 52-week low/high is $0.001/$0.06.

Mymetics Corp. (MYMX)

The Dean reported previously on Mymetics Corp. (MYMX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Mymetics Corp. is developing next-generation preventative vaccines for infectious diseases. The Company's core technology and expertise are in the use of virosomes - lipid-based carriers containing functional fusion viral proteins with the ability to be combined with rationally designed antigens. Mymetics currently has five vaccines in their pipeline: Respiratory Syncytial Virus, Influenza, HIV-1/AIDS, Malaria and Herpes Simplex Virus. The Company's vision is to become the market leader in the development of new generation mucosal and virosomes based vaccines. Mymetics lists on the OTC Bulletin Board; the Company has their headquarters in Epalinges, Switzerland.

The design of the Company's vaccines is to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense. For some pathogens, this may be essential for the development of an effective prophylactic vaccine. Mymetics' influenza, HIV-1 and malaria vaccines have completed Phase I clinical trials in healthy human volunteers, while the RSV and HSV vaccine candidates are in preclinical development.

Mymetics' strategy is to extend the application of their key scientific approaches to new vaccines by exploiting the results and knowledge of mucosal protection based vaccines, and leveraging the effective and safe virosome vaccine delivery technology and expertise. They are working on the advancement of existing vaccine candidates up to maximum Phase II and the maintenance of a comprehensive IP portfolio. In addition, the Company's strategy involves a flexible cost model based on a combination of in-house expertise as well as best-in-class outsourcing and strategic partnerships with leading pharmaceuticals.

Last month, Mymetics announced the appointment of Grant E. Pickering as President and Chief Executive Officer of Mymetics and the election of Dr. Christopher S. Henney as Chairman of the Board of Directors. Mymetics further announced the appointments of Ulrich Burkhard of the Marcuard Family Office and Mr. Pickering to their Board of Directors. These changes are made in connection with the efforts of Mymetics to obtain additional financing and to advance the development of the Company's vaccine platform.

Mymetics Corp. (MYMX) closed Friday's session at $0.07, even with yesterday’s close. The average volume for the last 60 days is 85,524. The 52-week low/high is $0.01/$0.17.

graphic

The QualityStocks
Company Corner

graphic
graphic

Quasar Aerospace Industries, Inc. (QASP)

The QualityStocks Daily Newsletter would like to spotlight Quasar Aerospace Industries, Inc. (QASP). Today, Quasar Aerospace Industries, Inc. closed trading at $0.33, up 10.00% on 590 volume with 2 trades. The stock’s average daily volume over the past 60 days is 26,425, and its 52-week low/high is $0.01/2.40.

Quasar Aerospace Industries, Inc. (QASP) is an integrated aviation/aerospace corporation focused on executing an innovative and highly synergistic business strategy to develop competitive aircraft and train aircraft pilots. By combining several businesses in the aviation/aerospace industry with an integrated and self-supporting network, the company will be able to operate in a more complex environment and achieve greater success.

Rather than forcing acquired business to conform to a master corporate plan, Quasar allows these entities to retain their operational independence and unique corporate cultures. In doing so, the resources, talents, insight, experience, and market potential of each will be supported and enhanced in a cooperative process, leading to increased productivity, efficiency, and scalable economies for increased profitability and market relevance.

Quasar's strategic vision is centered on two core principles: (1) a phased approach to the development of individual acquisitions and opportunities to insure early profitability and minimize financial risk through time, and (2) the development of an integrated network of companies whose synergies will enhance profitability throughout the company. Quasar targets companies with a proven track record and significant consolidated cash flow to expand its business with the support of positive consolidated cash flow from day one.

Quasar currently owns Atlantic Aviation, Inc., a wholly owned subsidiary that provides high-quality flight training programs; Quasar Aircraft Corporation, a wholly owned Nevada corporation; A-Cent Aviation, a wholly owned subsidiary recognized as a leader in pilot training, aircraft sales, and aircraft management in the Colorado Springs area; and Corporate Air Repair, LLC, a provider of aircraft maintenance and repair services (Quasar owns 1/3). Disclaimer

Quasar Aerospace Industries, Inc. Company Blog

Quasar Aerospace Industries, Inc. News:

CATS Application Approved, Management Change, Conference Call

Quasar Applies to Be an FAA CATS Testing Center and Schedules Conference Call

Quasar Achieves Mass Visibility at First Coast School Expo

TiVUS, Inc. (TIVU)

The QualityStocks Daily Newsletter would like to spotlight TiVUS, Inc. (TIVU). Today, TiVUS, Inc. closed trading at $0.0003, up 50.00%, on 41,544,500 volume with 20 trades. The stock’s average daily volume over the past 60 days is 38,488,078, and its 52-week low/high is $0.0001/0.022.

TiVUS, Inc. (TIVU) is a cutting edge provider of information, content distribution, media management and secure communications to the hospitality industry. The company's state of the art digital technology platform and Internet Protocol (IP) infrastructure presents hotels with a valuable opportunity to generate new revenue while enhancing guests' experiences by providing content that is more relevant to their unique interests.

The company's integrated platform stands far beyond the competition, offering unparalleled guest services such as messaging, folio review, express check outs, energy management and other personalized services while providing the traditional services of Free to Guest (FTG) programming, Video-On-Demand programming, a highly secured high speed internet service and many other interactive services such as gaming.

By combining TV and the web world through unparalleled IPTV/HDTV service, hotels are able to generate additional income through commercial spots, advertisements of local tourist services, hotel promotions and more. Features of the platform includes remote administration, support for more than twenty languages, easy installation and a comprehensive hotel services menu capable of providing detailed information about the hotel and upcoming activities, billing information, room service, guest messages and wake-up services.

The system's architecture consists of a Network Operating Center (NOC) and local hotel servers connected through a point-to-point broadband network. As each guest accesses the network, the resulting traffic generated undergoes analysis based on various criteria. This includes behavioral, geographical, seasonality, and more. Using this data, hotels are able to ensure advertisers maximum value for their advertising budget. Disclaimer

TiVUS, Inc. Company Blog

TiVUS, Inc. News:

TiVUS Begins Caribbean Operations

TiVUS Names Steven D. Truckenmiller EVP

TiVUS Offers Free-to-Guest Hotel TV Digital Programming

GlobalWise Investments, Inc. (GWIV)

The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $1.59, even with yesterday's close, on 2,650 volume with 5 trades. The stock’s average daily volume over the past 60 days is 7,336, and its 52-week low/high is $1.02/1.87.

GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.

GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.

The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.

GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer

GlobalWise Investments Company Blog

GlobalWise Investments News:

GlobalWise Provides Shareholder Update and Reports International Expansion to Latin America

GlobalWise Announces Channel Sales Partnership With the eVero Corporation

GlobalWise Announces Channel Sales Partnership With FormFast

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.40, off by 5.88% on 52,851 volume with 22 trades. The stock’s average daily volume over the past 60 days is 188,676, and its 52-week low/high is $0.3412/1.20.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces New Stem Cell Manufacturing Technologies to Support its Therapeutic Programs

International Stem Cell Corporation Appoints MZ Group as its Investor Relations Firm

ISCO Scientists to Present Results of Recent Stem Cell Research on Parkinson’s Disease at Annual Meeting of American Academy of Neurology

Quasar Aerospace Industries, Inc. (QASP) is “One to Watch”

Quasar Aerospace Industries is an integrated aviation/aerospace corporation focused on executing an innovative and highly synergistic business strategy to develop competitive aircraft and train aircraft pilots. By combining several businesses in the aviation/aerospace industry with an integrated and self-supporting network, the company will be able to operate in a more complex environment and achieve greater success.

Rather than forcing acquired business to conform to a master corporate plan, Quasar allows these entities to retain their operational independence and unique corporate cultures. In doing so, the resources, talents, insight, experience, and market potential of each will be supported and enhanced in a cooperative process, leading to increased productivity, efficiency, and scalable economies for increased profitability and market relevance.

Quasar’s strategic vision is centered on two core principles: (1) a phased approach to the development of individual acquisitions and opportunities to insure early profitability and minimize financial risk through time, and (2) the development of an integrated network of companies whose synergies will enhance profitability throughout the company. Quasar targets companies with a proven track record and significant consolidated cash flow to expand its business with the support of positive consolidated cash flow from day one.

Quasar currently owns Atlantic Aviation, Inc., a wholly owned subsidiary that provides high-quality flight training programs; Quasar Aircraft Corporation, a wholly owned Nevada corporation; A-Cent Aviation, a wholly owned subsidiary recognized as a leader in pilot training, aircraft sales, and aircraft management in the Colorado Springs area; and Corporate Air Repair, LLC, a provider of aircraft maintenance and repair services (Quasar owns 1/3).

SilverSun Technologies, Inc. (SSNT) and the Internal Turnaround

When one thinks of company turnarounds, it’s normal to imagine outside investors bringing in their own people, restructuring everything, perhaps chopping off various company operations, or even pointing the company to a brand new market. More common, however, is the internal turnaround, sometimes led by a new CEO, but often simply initiated by a transition in thinking within the existing executive team. Some attempts are successful, others are not. Indeed it is said that the quality of a company is best measured by how they respond to difficult times.

Such is the case with SilverSun Technologies, a nationwide small business IT services provider operating through its subsidiaries. Just 18 months ago, the company was facing a long string of flat annual sales, generating a little over $7 million in yearly revenue, together with significant operating losses, $2 million in convertible debt, and an industry still reeling from the recession. And yet, instead of outsiders swooping down to kick the company in a different direction, rescue came from the inside. The economy was still a struggle, but one thing the company seemed to have going for it was a team of people that, as company CEO Mark Meller put it, “refuse to accept mediocrity, much less failure as an outcome to any challenge”.

Through a broad mix of operational, product, and service evaluations and transformations, the company essentially pulled itself up by its own bootstraps. By 2012, SilverSun was a different company. Not only did they achieve record annual revenues for 2011, a jump of some 40% over 2010, the company realized an operating profit of $260,000. At the same time, they eliminated all debt, other than ordinary accounts payable, and secured a revolving line of credit to the tune of $750,000. They even closed on the acquisition of selected assets of IncorTech (an accounting, technology, and business consulting company), and signed a letter of intent to acquire the assets of HighTower, a Chicago-based Sage business and development partner.

Turnaround or not, SilverSun is convinced that it is just beginning. The company is now on a stated mission to grow their annual revenues five-fold from their current level of approximately $10.5 million to more than $50 million in the next 36 months.

For additional information, visit SilverSun’s website at www.SilverSunTech.co

International Stem Cell Corp. (ISCO) is “One to Watch”

International Stem Cell Corp. specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company’s scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology.

Victory Energy Corp. (VYEY) Makes Major Progress, Sets 2012 Goals

Victory Energy is a domestic energy company engaged in the production of oil and natural gas through its onshore wells in west Texas, Oklahoma, and New Mexico. Currently, the company has 17 wells in production with the capacity to expand to an additional 31 wells. VYEY seeks to maximize shareholder value over the long term by increasing accessible oil reserves, producing more oil, lowering its costs, and carefully managing the capital entrusted to it. For 2012, the company looks to invest in acreage with proved reserves in order to minimize its exploration and development costs.

To gauge how the company has progressed, the 2012 goals have to be viewed in the context of the major accomplishments made in 2011. In 2011, VYEY completed a massive overhaul of its operations from top to bottom.

Several changes were made to its management team in 2011 that became effective this year. On January 10, 2012, Mr. Mark W. Biggers joined the company as the new Chief Financial Officer. Mr. Biggers had previously served as a Senior Director in the Energy Practice of Alvarez and Marsal. Prior to Alvarez and Marsal, Mr. Biggers had spent over 20 years with Mobil Oil Corporation in a variety of roles. Also in January of this year, Mr. Kenneth Hill was selected as President and Chief Executive Officer. Mr. Hill had previously served as the company’s Vice President of Operations. The management team now has a total of 107 combined years of industry experience, truly an asset that can be put to use immediately.

Victory Energy became current on all filings with the SEC. Full compliance makes the company more attractive to creditors and investors.

The company settled a major lawsuit with a former employee, and secured future access to capital through the negotiation of a partnership agreement, the “Aurora Partnership.” VYEY is the managing partner of the Aurora entity, owning at 50% interest in the venture. The company raised $3.1 million in funds and converted $1.2 million in debt to equity.

At year end on December 31, 2011, VYEY had $475,623 of cash and cash equivalents, as compared to $111,572 at December 31, 2010. At December 31, 2011, total assets increased by $790,330 to $1,553,363 as compared to total assets of $538,729 as of December 31, 2010. This increase in total assets includes a net increase of $552,421 of investments in oil & natural gas properties.

This represented a 100% increase in oil in comparison to the prior fiscal year. 2011 saw the company drill 9 exploration wells and acquire interests in 3 producing wells. These wells represented the first acquisition of oil and gas properties for the company since 2009. Also, the company began to transition its management offices from California to Texas.

Having made such drastic changes in 2011, where does the company want to go from here?

For the rest of 2012, Victory, says its primary objective is to create long-term shareholder value by increasing oil and gas reserves, improving financial returns through pumping more oil and cutting overhead, and prudently managing its capital. First and foremost will be the completion of moving all back-office and management operations to Texas. Next will be the selection of an auditor in Texas that has exploration and production audit experience.

Victory ended the month of February 2012 in an enviable position: No debt and $1.7 million in cash. This resulted from a reverse stock split and the conversion of debt to equity. Victory expects to spend about $4.0 million this year on capital expenditures and exploration activities. Additional money may be spent to purchase acreage with resources where the price of the land does not accurately reflect its true value. Several prospects have already been identified.

The primary focus of 2012 capital and exploration expenditures is to further develop existing assets, including the Bootleg Canyon Ellenberger Field where Victory owns a 5% working interest, the recently announced Lightnin’ Prospect in Glasscock County, Texas, where VYEY holds a 75% working interest, and the ClearWater Wolfberry resource play where the company owns a 1.5% working interest. VYEY also intends to explore the oil potential of the Tippett shale formation in its Adams-Baggett wells where the company holds a 100% working interest in seven wells and a 50% working interest in two wells.

Victory plans to drill or recomplete at least 15 new wells on current properties at an average working interest of 24% in partnership with Aurora. This compares very favorably to its participation in 9 new wells in 2011 at an average working interest of 3.3%.

Victory forecasts an increase in production of about 80% in 2012 over 2011 depending on its drilling schedule and the success of its operations. Last year, the company produced 8 MBOE and the target this year is between 42 to 46 MBOE. Of the 80% increase, half is expected to be oil and the rest will be natural gas.

Victory’s changes include an expected decline of 40%, to $1.2 million, in general and administrative expenses compared to last year’s figure of $3 million. The decline is the result of the elimination of significant non-recurring expenses through 2011 and early Q1 of 2012. The company expects that consolidation of all company personnel and service-related companies to Texas will also contribute to better efficiency and lower operating costs.

Investors drawn to conservative gas and oil plays, seeking to produce oil from proven fields, should keep a close watch on VYEY and see if it can cross the 2012 finish line in first place.

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Daily Market Beat
(BOIL)

2.

OTCPicks
(BPAC)

3.

HotShotStocks
(VIIC)

graphic
By The Numbers Charts
QualitystockTwits

Daily Sponsors

The QualityStocks By The Numbers Report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251